Request for Covid-19 Impact Assessment of this Report
Market Segmentation:
By Type (Cell Viability Assay, Cytotoxicity Assay, Cell Death Assay, Cell Proliferation Assay, Others), Product & Services (Consumables, Services, Instruments and Software), Technology (Flow Cytometry, High Throughput Screening, High Content Screening, Label Free Detection), Application (Drug Discovery, Basic Research, Others), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutions, Government Organizations, Others), Distribution Channel (Direct, Indirect), Geography (Europe, North America, Asia-Pacific, South America, Middle East and Africa).
Some of the major factors contributing to the growth of the market:
• Rising demands for novel small molecules, bio-therapeutic and cell based therapies
• Increasing life sciences R&D expenditure
• Increasing incidence of chronic diseases
Market Players:
The key market players for global cell based assays market are listed below:
• GENERAL ELECTRIC
• Danaher
• Agilent Technologies, Inc.
• Thermo Fisher Scientific Inc.
• Merck KGaA
• PerkinElmer Inc.
• Bio-Rad Laboratories, Inc.
• ATCC
• Aurelia Bioscience Ltd
• BD
• BioAgilytix Labs
• BioVision Inc.
• Cell Signaling Technology, Inc
• Cisbio
• Enzo Biochem Inc
• Eurofins Scientific
• LakePharma, Inc
• Lonza
• Miltenyi Biotec
• XenoDiagnostics, LLC
1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.3 OVERVIEW OF GLOBAL CELL BASED ASSAYS MARKET 28
1.4 LIMITATIONS 29
1.5 MARKETS COVERED 30
2 MARKET SEGMENTATION 33
2.1 MARKETS COVERED 33
2.2 GLOBAL CELL BASED ASSAYS MARKET: GEOGRAPHICAL SCOPE 34
2.3 YEARS CONSIDERED FOR THE STUDY 35
2.4 CURRENCY AND PRICING 35
2.5 DBMR TRIPOD DATA VALIDATION MODEL 36
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 39
2.7 DBMR MARKET POSITION GRID (ON THE BASIS OF PRODUCTS) 40
2.8 DBMR MARKET POSITION GRID 41
2.9 DBMR VENDOR SHARE ANALYSIS 42
2.10 MULTIVARIATE MODELING 43
2.11 PRODUCTS LIFELINE CURVE 44
2.12 SECONDARY SOURCES 45
2.13 ASSUMPTIONS 45
3 MARKET OVERVIEW 46
3.1 DRIVERS 48
3.1.1 INCREASING INCIDENCE OF CHRONIC DISEASES 48
3.1.2 RISING DEMANDS FOR NOVEL SMALL MOLECULES, BIO-THERAPEUTIC AND CELL BASED THERAPIES 50
3.1.3 INCREASE IN RESEARCH AND DEVELOPMENT EXPENDITURE 51
3.2 RESTRAINT 53
3.2.1 STRINGENT REGULATORY REQUIREMENTS 53
3.2.2 HIGH COST OF INSTRUMENTATION 53
3.3 OPPORTUNITIES 54
3.3.1 TECHNOLOGICAL ADVANCEMENTS 54
3.3.2 STRATEGIC INITIATIVE BY THE MARKET PLAYERS 54
3.4 CHALLENGES 55
3.4.1 CHALLENGING ANALYSIS PROCEDURE 55
4 EXECUTIVE SUMMARY 56
5 PREMIUM INSIGHTS 58
6 GLOBAL CELL-BASED ASSAYS MARKET, BY TYPE 60
6.1 OVERVIEW 61
6.2 CELL VIABILITY ASSAY 63
6.3 CYTOTOXICITY ASSAY 64
6.4 CELL PROLIFERATION ASSAY 64
6.5 CELL DEATH ASSAY 65
6.6 OTHERS 65
7 GLOBAL CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICES 66
7.1 OVERVIEW 67
7.2 CONSUMABLES 69
7.2.1 ASSAY KITS 70
7.2.2 CELL LINES 70
7.2.2.1 Primary Cell Lines 70
7.2.2.2 Stem Cell Lines 70
7.2.2.3 Immortalized Cell Lines 70
7.2.3 REAGENTS 70
7.2.4 MICROPLATES 70
7.3 SERVICES 71
7.4 INSTRUMENTS AND SOFTWARE 71
8 GLOBAL CELL-BASED ASSAYS MARKET, BY TECHNOLOGY 72
8.1 OVERVIEW 73
8.2 HIGH THROUGHPUT SCREENING 75
8.3 FLOW CYTOMETRY 75
8.4 HIGH CONTENT SCREENING 76
8.5 LABEL FREE DETECTION 76
9 GLOBAL CELL-BASED ASSAYS MARKET, BY APPLICATION 77
9.1 OVERVIEW 78
9.2 DRUG DISCOVERY 80
9.2.1 PREDICTIVE TOXICOLOGY 80
9.2.2 PHARMACODYNAMIC STUDIES 81
9.2.3 ADME RESEARCH 81
9.3 BASIC RESEARCH 81
9.4 OTHERS 81
10 GLOBAL CELL-BASED ASSAYS MARKET, BY END USER 82
10.1 OVERVIEW 83
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 85
10.3 CONTRACT RESEARCH ORGANIZATIONS 86
10.4 ACADEMIC & RESEARCH INSTITUTIONS 86
10.5 GOVERNMENT ORGANIZATIONS 87
10.6 OTHERS 87
11 GLOBAL CELL-BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL 88
11.1 OVERVIEW 89
11.2 DIRECT 91
11.3 INDIRECT 91
12 GLOBAL CELL BASED ASSAY MARKET, BY GEOGRAPHY 92
12.1 OVERVIEW 93
12.2 NORTH AMERICA 98
12.2.1 U.S. 104
12.2.2 CANADA 107
12.2.3 MEXICO 110
12.3 EUROPE 113
12.3.1 GERMANY 119
12.3.2 FRANCE 122
12.3.3 UNITED KINGDOM 125
12.3.4 ITALY 128
12.3.5 SPAIN 131
12.3.6 RUSSIA 134
12.3.7 NETHERLANDS 137
12.3.8 SWITZERLAND 140
12.3.9 BEGIUM 143
12.3.10 TURKEY 146
12.3.11 REST OF EUROPE 149
12.4 ASIA-PACIFIC 150
12.4.1 CHINA 156
12.4.2 JAPAN 159
12.4.3 SOUTH KOREA 162
12.4.4 INDIA 165
12.4.5 SINGAPORE 168
12.4.6 AUSTRALIA 171
12.4.7 THAILAND 174
12.4.8 MALAYSIA 177
12.4.9 INDONESIA 180
12.4.10 PHILIPPINES 183
12.4.11 REST OF ASIA-PACIFIC 186
12.5 SOUTH AMERICA 187
12.5.1 BRAZIL 193
12.5.2 REST OF SOUTH AMERICA 196
12.6 MIDDLE EAST AND AFRICA 197
12.6.1 SOUTH AFRICA 203
12.6.2 REST OF MIDDLE EAST AND AFRICA 206
13 GLOBAL CELL BASED ASSAYS MARKET FOR PRODUCTS, COMPANY LANDSCAPE 207
13.1 COMPANY SHARE ANALYSIS: GLOBAL 207
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 208
13.3 COMPANY SHARE ANALYSIS: EUROPE 209
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 210
14 GLOBAL CELL BASED ASSAYS MARKET FOR SERVICES, COMPANY LANDSCAPE 211
14.1 COMPANY SHARE ANALYSIS: GLOBAL 211
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 212
14.3 COMPANY SHARE ANALYSIS: EUROPE 213
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 214
15 COMPANY PROFILE 215
15.1 GENERAL ELECTRIC 215
15.1.1 COMPANY SNAPSHOT 215
15.1.2 REVENUE ANALYSIS 215
15.1.3 COMPANY SHARE ANALYSIS 216
15.1.4 PRODUCT PORTFOLIO 216
15.1.5 RECENT DEVELOPMENTS 217
15.2 DANAHER 218
15.2.1 COMPANY SNAPSHOT 218
15.2.2 REVENUE ANALYSIS 218
15.2.3 COMPANY SHARE ANALYSIS 219
15.2.4 PRODUCT PORTFOLIO 219
15.2.5 RECENT DEVELOPMENT 222
15.3 AGILENT TECHNOLOGIES, INC. 223
15.3.1 19.1 COMPANY SNAPSHOT 223
15.3.2 REVENUE ANALYSIS 223
15.3.3 COMPANY SHARE ANALYSIS 224
15.3.4 PRODUCT PORTFOLIO 224
15.3.5 RECENT DEVELOPMENTS 226
15.4 THERMO FISHER SCIENTIFIC INC 227
15.4.1 COMPANY SNAPSHOT 227
15.4.2 REVENUE ANALYSIS 227
15.4.3 COMPANY SHARE ANALYSIS 228
15.4.4 PRODUCT PORTFOLIO 228
15.4.5 RECENT DEVELOPMENT 254
15.5 MERCK KGAA 255
15.5.1 COMPANY SNAPSHOT 255
15.5.2 REVENUE ANALYSIS 255
15.5.3 PRODUCT PORTFOLIO 256
15.5.4 RECENT DEVELOPMENT 261
15.6 PERKINELMER INC, INC. 262
15.6.1 COMPANY SNAPSHOT 262
15.6.2 REVENUE ANALYSIS 262
15.6.3 PRODUCT PORTFOLIO 263
15.6.4 RECENT DEVELOPMENT 268
15.7 BIO-RAD LABORATORIES, INC. 269
15.7.1 COMPANY SNAPSHOT 269
15.7.2 REVENUE ANALYSIS 269
15.7.3 PRODUCT PORTFOLIO 270
15.7.4 RECENT DEVELOPMENTS 272
15.8 ATCC 273
15.8.1 COMPANY SNAPSHOT 273
15.8.2 PRODUCT PORTFOLIO 273
15.8.3 RECENT DEVELOPMENT 274
15.9 AURELIA BIOSCIENCE LTD. 275
15.9.1 COMPANY SNAPSHOT 275
15.9.2 SERVICE PORTFOLIO 275
15.9.3 RECENT DEVELOPMENT 275
15.10 BD 276
15.10.1 COMPANY SNAPSHOT 276
15.10.2 REVENUE ANALYSIS 276
15.10.3 PRODUCT PORTFOLIO 277
15.10.4 RECENT DEVELOPMENTS 279
15.11 BIOAGILYTIX LABS 280
15.11.1 COMPANY SNAPSHOT 280
15.11.2 SERVICE PORTFOLIO 280
15.11.3 RECENT DEVELOPMENTS 280
15.12 BIOVISION INC. 281
15.12.1 COMPANY SNAPSHOT 281
15.12.2 PRODUCT PORTFOLIO 281
15.12.3 RECENT DEVELOPMENT 289
15.13 CELL SIGNALING TECHNOLOGY, INC. 290
15.13.1 COMPANY SNAPSHOT 290
15.13.2 PRODUCT PORTFOLIO 290
15.13.3 RECENT DEVELOPMENT 295
15.14 CISBIO 296
15.14.1 COMPANY SNAPSHOT 296
15.14.2 PRODUCT PORTFOLIO 296
15.14.3 RECENT DEVELOPMENT 304
15.15 ENZO BIOCHEM INC. 305
15.15.1 COMPANY SNAPSHOT 305
15.15.2 REVENUE ANALYSIS 305
15.15.3 PRODUCT PORTFOLIO 306
15.15.4 RECENT DEVELOPMENT 307
15.16 EUROFINS SCIENTIFIC 308
15.16.1 COMPANY SNAPSHOT 308
15.16.2 REVENUE ANALYSIS 308
15.16.3 PRODUCT AND SERVICE PORTFOLIO 309
15.16.4 RECENT DEVELOPMENTS 310
15.17 LAKEPHARMA, INC. 311
15.17.1 COMPANY SNAPSHOT 311
15.17.2 SERVICE PORTFOLIO 311
15.17.3 RECENT DEVELOPMENT 311
15.18 LONZA 312
15.18.1 COMPANY SNAPSHOT 312
15.18.2 REVENUE ANALYSIS 312
15.18.3 SERVICE PORTFOLIO 313
15.18.4 RECENT DEVELOPMENT 315
15.19 MILTENYI BIOTEC 316
15.19.1 COMPANY SNAPSHOT 316
15.19.2 15.2 PRODUCT PORTFOLIO 316
15.19.3 RECENT DEVELOPMENT 317
15.20 XENO DIAGNOSTICS, LLC. 318
15.20.1 COMPANY SNAPSHOT 318
15.20.2 PRODUCT PORTFOLIO 318
15.20.3 RECENT DEVELOPMENT 319
16 QUESTIONNAIRE 320
17 RELATED REPORTS 324
UU
TABLE 1 AGEING WORLD POPULATION (IN MILLIONS) 49
TABLE 2 TABLE REGIONS BY DIABETES PREVALENCE (%) IN ELDERLY POPULATION IN 2017 AND 2045 (IN MILLIONS) 49
TABLE 3 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE 52
TABLE 4 GLOBAL CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 63
TABLE 5 GLOBAL CELL VIABILITY ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 63
TABLE 6 GLOBAL CYTOTOXICITY ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 64
TABLE 7 GLOBAL CELL PROLIFERATION ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 64
TABLE 8 GLOBAL CELL DEATH ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 65
TABLE 9 GLOBAL OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 65
TABLE 10 GLOBAL CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 69
TABLE 11 GLOBAL CONSUMABLES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 69
TABLE 12 GLOBAL CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 69
TABLE 13 GLOBAL CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 70
TABLE 14 GLOBAL SERVICES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 71
TABLE 15 GLOBAL INSTRUMENTS AND SOFTWARE IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 71
TABLE 16 GLOBAL CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 74
TABLE 17 GLOBAL HIGH THROUGHPUT SCREENING IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 75
TABLE 18 GLOBAL FLOW CYTOMETRY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 75
TABLE 19 GLOBAL HIGH CONTENT SCREENING IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 76
TABLE 20 GLOBAL LABEL FREE DETECTION IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 76
TABLE 21 GLOBAL CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 80
TABLE 22 GLOBAL DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 80
TABLE 23 GLOBAL DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 80
TABLE 24 GLOBAL BASIC RESEARCH IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 81
TABLE 25 GLOBAL OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 81
TABLE 26 GLOBAL CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 85
TABLE 27 GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 85
TABLE 28 GLOBAL CONTRACT RESEARCH ORGANIZATIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 86
TABLE 29 GLOBAL ACADEMIC & RESEARCH INSTITUTIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 86
TABLE 30 GLOBAL GOVERNMENT ORGANIZATIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 87
TABLE 31 GLOBAL OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 87
TABLE 32 GLOBAL CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 90
TABLE 33 GLOBAL DIRECT IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 91
TABLE 34 GLOBAL INDIRECT IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 91
TABLE 35 GLOBAL CELL BASED ASSAY MARKET, BY GEOGRAPHY, 2017–2026 (USD MILLION) 97
TABLE 36 NORTH AMERICA CELL BASED ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 101
TABLE 37 NORTH AMERICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 101
TABLE 38 NORTH AMERICA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 101
TABLE 39 NORTH AMERICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 101
TABLE 40 NORTH AMERICA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 102
TABLE 41 NORTH AMERICA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 102
TABLE 42 NORTH AMERICA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 102
TABLE 43 NORTH AMERICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 102
TABLE 44 NORTH AMERICA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 103
TABLE 45 NORTH AMERICA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 103
TABLE 46 U.S. CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 104
TABLE 47 U.S. CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 104
TABLE 48 U.S. CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 104
TABLE 49 U.S. CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 105
TABLE 50 U.S. CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 105
TABLE 51 U.S. CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 105
TABLE 52 U.S. DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 105
TABLE 53 U.S. CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 106
TABLE 54 U.S CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 106
TABLE 55 CANADA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 107
TABLE 56 CANADA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 107
TABLE 57 CANADA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 107
TABLE 58 CANADA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 108
TABLE 59 CANADA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 108
TABLE 60 CANADA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 108
TABLE 61 CANADA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 108
TABLE 62 CANADA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 109
TABLE 63 CANADA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 109
TABLE 64 MEXICO CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 110
TABLE 65 MEXICO CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 110
TABLE 66 MEXICO CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 110
TABLE 67 MEXICO CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 111
TABLE 68 MEXICO CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 111
TABLE 69 MEXICO CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 111
TABLE 70 MEXICO DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 111
TABLE 71 MEXICO CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 112
TABLE 72 MEXICO CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 112
TABLE 73 EUROPE CELL BASED ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 116
TABLE 74 EUROPE CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 116
TABLE 75 EUROPE CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 116
TABLE 76 EUROPE CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 117
TABLE 77 EUROPE CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 117
TABLE 78 EUROPE CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 117
TABLE 79 EUROPE CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 117
TABLE 80 EUROPE DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 118
TABLE 81 EUROPE CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 118
TABLE 82 EUROPE CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 118
TABLE 83 GERMANY CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 119
TABLE 84 GERMANY CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 119
TABLE 85 GERMANY CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 119
TABLE 86 GERMANY CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 120
TABLE 87 GERMANY CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 120
TABLE 88 GERMANY CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 120
TABLE 89 GERMANY DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 120
TABLE 90 GERMANY CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 121
TABLE 91 FRANCE CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 122
TABLE 92 FRANCE CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 122
TABLE 93 FRANCE CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 122
TABLE 94 FRANCE CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 123
TABLE 95 FRANCE CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 123
TABLE 96 FRANCE CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 123
TABLE 97 FRANCE DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 123
TABLE 98 FRANCE CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 124
TABLE 99 FRANCE CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 124
TABLE 100 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 125
TABLE 101 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 125
TABLE 102 UNITED KINGDOM CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 125
TABLE 103 UNITED KINGDOM CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 126
TABLE 104 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 126
TABLE 105 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 126
TABLE 106 UNITED KINGDOM DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 126
TABLE 107 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 127
TABLE 108 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 127
TABLE 109 ITALY CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 128
TABLE 110 ITALY CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 128
TABLE 111 ITALY CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 128
TABLE 112 ITALY CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 129
TABLE 113 ITALY CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 129
TABLE 114 ITALY CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 129
TABLE 115 ITALY DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 129
TABLE 116 ITALY CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 130
TABLE 117 ITALY CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 130
TABLE 118 SPAIN CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 131
TABLE 119 SPAIN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 131
TABLE 120 SPAIN CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 131
TABLE 121 SPAIN CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 132
TABLE 122 SPAIN CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 132
TABLE 123 SPAIN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 132
TABLE 124 SPAIN DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 132
TABLE 125 SPAIN CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 133
TABLE 126 SPAIN CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 133
TABLE 127 RUSSIA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 134
TABLE 128 RUSSIA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 134
TABLE 129 RUSSIA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 134
TABLE 130 RUSSIA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 135
TABLE 131 RUSSIA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 135
TABLE 132 RUSSIA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 135
TABLE 133 RUSSIA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 135
TABLE 134 RUSSIA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 136
TABLE 135 RUSSIA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 136
TABLE 136 NETHERLANDS CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 137
TABLE 137 NETHERLANDS CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 137
TABLE 138 NETHERLANDS CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 137
TABLE 139 NETHERLANDS CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 138
TABLE 140 NETHERLANDS CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 138
TABLE 141 NETHERLANDS CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 138
TABLE 142 NETHERLANDS DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 138
TABLE 143 NETHERLANDS CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 139
TABLE 144 NETHERLANDS CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 139
TABLE 145 SWITZERLAND CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 140
TABLE 146 SWITZERLAND CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 140
TABLE 147 SWITZERLAND CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 140
TABLE 148 SWITZERLAND CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 141
TABLE 149 SWITZERLAND CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 141
TABLE 150 SWITZERLAND CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 141
TABLE 151 SWITZERLAND DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 141
TABLE 152 SWITZERLAND CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 142
TABLE 153 SWITZERLAND CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 142
TABLE 154 BELGIUM CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 143
TABLE 155 BELGIUM CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 143
TABLE 156 BELGIUM CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 143
TABLE 157 BELGIUM CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 144
TABLE 158 BELGIUM CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 144
TABLE 159 BELGIUM CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 144
TABLE 160 BELGIUM DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 144
TABLE 161 BELGIUM CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 145
TABLE 162 BELGIUM CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 145
TABLE 163 TURKEY CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 146
TABLE 164 TURKEY CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 146
TABLE 165 TURKEY CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 146
TABLE 166 TURKEY CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 147
TABLE 167 TURKEY CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 147
TABLE 168 TURKEY CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 147
TABLE 169 TURKEY DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 147
TABLE 170 TURKEY CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 148
TABLE 171 TURKEY CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 148
TABLE 172 REST OF EUROPE CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 149
TABLE 173 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 153
TABLE 174 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 153
TABLE 175 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 153
TABLE 176 ASIA-PACIFIC CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 154
TABLE 177 ASIA-PACIFIC CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 154
TABLE 178 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 154
TABLE 179 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 154
TABLE 180 ASIA-PACIFIC DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 155
TABLE 181 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 155
TABLE 182 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 155
TABLE 183 CHINA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 156
TABLE 184 CHINA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 156
TABLE 185 CHINA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 156
TABLE 186 CHINA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 157
TABLE 187 CHINA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 157
TABLE 188 CHINA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 157
TABLE 189 CHINA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 157
TABLE 190 CHINA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 158
TABLE 191 CHINA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 158
TABLE 192 JAPAN CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 159
TABLE 193 JAPAN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 159
TABLE 194 JAPAN CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 159
TABLE 195 JAPAN CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 160
TABLE 196 JAPAN CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 160
TABLE 197 JAPAN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 160
TABLE 198 JAPAN DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 160
TABLE 199 JAPAN CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 161
TABLE 200 JAPAN CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 161
TABLE 201 SOUTH KOREA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 162
TABLE 202 SOUTH KOREA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 162
TABLE 203 SOUTH KOREA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 162
TABLE 204 SOUTH KOREA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 163
TABLE 205 SOUTH KOREA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 163
TABLE 206 SOUTH KOREA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 163
TABLE 207 SOUTH KOREA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 163
TABLE 208 SOUTH KOREA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 164
TABLE 209 SOUTH KOREA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 164
TABLE 210 INDIA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 165
TABLE 211 INDIA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 165
TABLE 212 INDIA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 165
TABLE 213 INDIA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 166
TABLE 214 INDIA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 166
TABLE 215 INDIA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 166
TABLE 216 INDIA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 166
TABLE 217 INDIA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 167
TABLE 218 INDIA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 167
TABLE 219 SINGAPORE CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 168
TABLE 220 SINGAPORE CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 168
TABLE 221 SINGAPORE CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 168
TABLE 222 SINGAPORE CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 169
TABLE 223 SINGAPORE CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 169
TABLE 224 SINGAPORE CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 169
TABLE 225 SINGAPORE DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 169
TABLE 226 SINGAPORE CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 170
TABLE 227 SINGAPORE CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 170
TABLE 228 AUSTRALIA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 171
TABLE 229 AUSTRALIA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 171
TABLE 230 AUSTRALIA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 171
TABLE 231 AUSTRALIA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 172
TABLE 232 AUSTRALIA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 172
TABLE 233 AUSTRALIA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 172
TABLE 234 AUSTRALIA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 172
TABLE 235 AUSTRALIA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 173
TABLE 236 AUSTRALIA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 173
TABLE 237 THAILAND CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 174
TABLE 238 THAILAND CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 174
TABLE 239 THAILAND CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 174
TABLE 240 THAILAND CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 175
TABLE 241 THAILAND CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 175
TABLE 242 THAILAND CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 175
TABLE 243 THAILAND DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 175
TABLE 244 THAILAND CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 176
TABLE 245 THAILAND CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 176
TABLE 246 MALAYSIA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 177
TABLE 247 MALAYSIA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 177
TABLE 248 MALAYSIA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 177
TABLE 249 MALAYSIA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 178
TABLE 250 MALAYSIA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 178
TABLE 251 MALAYSIA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 178
TABLE 252 MALAYSIA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 178
TABLE 253 MALAYSIA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 179
TABLE 254 MALAYSIA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 179
TABLE 255 INDONESIA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 180
TABLE 256 INDONESIA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 180
TABLE 257 INDONESIA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 180
TABLE 258 INDONESIA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 181
TABLE 259 INDONESIA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 181
TABLE 260 INDONESIA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 181
TABLE 261 INDONESIA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 181
TABLE 262 INDONESIA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 182
TABLE 263 INDONESIA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 182
TABLE 264 PHILIPPINES CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 183
TABLE 265 PHILIPPINES CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 183
TABLE 266 PHILIPPINES CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 183
TABLE 267 PHILIPPINES CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 184
TABLE 268 PHILIPPINES CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 184
TABLE 269 PHILIPPINES CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 184
TABLE 270 PHILIPPINES DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 184
TABLE 271 PHILIPPINES CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 185
TABLE 272 PHILIPPINES CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 185
TABLE 273 REST OF ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 186
TABLE 274 SOUTH AMERICA CELL BASED ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 190
TABLE 275 SOUTH AMERICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 190
TABLE 276 SOUTH AMERICA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 190
TABLE 277 SOUTH AMERICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 190
TABLE 278 SOUTH AMERICA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 191
TABLE 279 SOUTH AMERICA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 191
TABLE 280 SOUTH AMERICA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 191
TABLE 281 SOUTH AMERICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 191
TABLE 282 SOUTH AMERICA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 192
TABLE 283 SOUTH AMERICA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 192
TABLE 284 BRAZIL CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 193
TABLE 285 BRAZIL CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 193
TABLE 286 BRAZIL CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 193
TABLE 287 BRAZIL CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 194
TABLE 288 BRAZIL CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 194
TABLE 289 BRAZIL CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 194
TABLE 290 BRAZIL DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 194
TABLE 291 BRAZIL CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 195
TABLE 292 BRAZIL CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 195
TABLE 293 REST OF SOUTH AMERICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 196
TABLE 294 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 200
TABLE 295 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 200
TABLE 296 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 200
TABLE 297 MIDDLE EAST AND AFRICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 200
TABLE 298 MIDDLE EAST AND AFRICA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 201
TABLE 299 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 201
TABLE 300 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 201
TABLE 301 MIDDLE EAST AND AFRICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 201
TABLE 302 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 202
TABLE 303 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 202
TABLE 304 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 203
TABLE 305 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 203
TABLE 306 SOUTH AFRICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 203
TABLE 307 SOUTH AFRICA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) 204
TABLE 308 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 204
TABLE 309 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 204
TABLE 310 SOUTH AFRICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 204
TABLE 311 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 205
TABLE 312 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) 205
TABLE 313 REST OF MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 206
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...